• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Who Benefits From Taking a Statin, and When?: On Fundamentally Restructuring Our Thinking Regarding Primary Prevention of Cardiovascular Disease.

作者信息

Leening Maarten J G

机构信息

Departments of Epidemiology and Cardiology, Erasmus MC-University Medical Center Rotterdam, The Netherlands. Department of Clinical Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA.

出版信息

Circulation. 2020 Sep;142(9):838-840. doi: 10.1161/CIRCULATIONAHA.120.048340. Epub 2020 Aug 31.

DOI:10.1161/CIRCULATIONAHA.120.048340
PMID:32866062
Abstract
摘要

相似文献

1
Who Benefits From Taking a Statin, and When?: On Fundamentally Restructuring Our Thinking Regarding Primary Prevention of Cardiovascular Disease.谁能从服用他汀类药物中获益，何时获益？：关于从根本上重塑我们对心血管疾病一级预防的认识。
Circulation. 2020 Sep;142(9):838-840. doi: 10.1161/CIRCULATIONAHA.120.048340. Epub 2020 Aug 31.
2
Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.心脏结局预防评估试验对他汀类药物用于心血管疾病一级预防的适用性影响：来自美国国家健康与营养检查调查的见解
Circulation. 2017 Nov 7;136(19):1860-1862. doi: 10.1161/CIRCULATIONAHA.117.029102.
3
Debate on adverse effects of statins.关于他汀类药物不良反应的争论。
Eur J Intern Med. 2014 Oct;25(8):e95. doi: 10.1016/j.ejim.2014.08.006. Epub 2014 Sep 16.
4
Statin Adherence and Poverty - The Wide Gap in Cardiovascular Prevention.
Cardiovasc Revasc Med. 2020 Aug;21(8):1022-1023. doi: 10.1016/j.carrev.2020.06.012. Epub 2020 Jun 10.
5
Real-world data show the effect of statins in primary prevention.
Eur J Prev Cardiol. 2023 Nov 30;30(17):1881-1882. doi: 10.1093/eurjpc/zwad231.
6
Statin therapy for primary prevention of cardiovascular disease.他汀类药物治疗用于心血管疾病一级预防。
JAMA. 2013 Dec 11;310(22):2451-2. doi: 10.1001/jama.2013.281348.
7
Summary for Patients: Benefits and Risks Associated With Statin Therapy for Primary Prevention in Old and Very Old Adults.患者总结：老年及高龄成年人他汀类药物一级预防治疗的获益与风险
Ann Intern Med. 2024 Jun;177(6):I18. doi: 10.7326/P24-0001. Epub 2024 May 28.
8
Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.他汀类药物在 >75 岁成年人中的使用与不良反应：来自患者和提供者脂质管理评估（PALM）登记处的见解。
J Am Heart Assoc. 2018 May 8;7(10):e008546. doi: 10.1161/JAHA.118.008546.
9
Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.在心血管疾病一级预防中确定他汀类药物适用人群时的个体化他汀类药物获益情况
Circulation. 2016 Apr 19;133(16):1574-81. doi: 10.1161/CIRCULATIONAHA.115.018383. Epub 2016 Mar 4.
10
[A statin pill too much].
Lakartidningen. 2011;108(43):2169-70; discussion 2170-1.

引用本文的文献

1
Implementation of the healthy heart tool- an algorithm with potential cardiometabolic health benefits in persons with severe mental illness.健康心脏工具的实施——一种对重度精神疾病患者具有潜在心脏代谢健康益处的算法。
BMC Psychiatry. 2025 Feb 25;25(1):172. doi: 10.1186/s12888-025-06578-w.
2
Inaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk.他汀类药物使用情况报告不准确会影响血脂指标的评估及其与冠状动脉疾病风险的关联。
Clin Chem. 2024 Mar 2;70(3):528-537. doi: 10.1093/clinchem/hvad223.